Table 2 BAL fluid analysis
From: Fluticasone impact on airway dendritic cells in smokers: a randomized controlled trial
Placebo | Fluticasone | Fluticasone/Salmeterol | ||||
|---|---|---|---|---|---|---|
Time point | A | B | A | B | A | B |
n | 14 | 14 | 14 | 14 | 14 | 14 |
Recovery (ml BAL fluid) | 62 (45 - 67) | 64 (48 - 71) | 63 (56–70) | 65 (37–72) | 62 (55–65) | 62 (54–70) |
Total cells (10 3 /ml BAL fluid) | 121 (17–487) | 190 (35–469) | 81 (38–284) | 93 (6–217) | 125 (36–409) | 97* (25–339) |
Macrophages (10 3 /ml BAL fluid) | 114 (15–447) | 181 (34–459) | 75 (32–263) | 86 (5–205) | 119 (32–397) | 88* (22–315) |
Lymphocytes (10 3 /ml BAL fluid) | 7.2 (0.5 - 34.1) | 5.6 (0.7 - 28.2) | 2.7 (0.6 - 13.1) | 4.1 (0.6 - 7.8) | 3.0 (1.0 - 39.1) | 3.2 (0.7 - 14.2) |
Neutrophils (10 3 /ml BAL fluid) | 2.1 (0.3 - 12.0) | 1.4 (0.0 - 5.0) | 1.6 (0.6 - 5.1) | 1.2 (0.2 - 6.1) | 2.9 (0.1 - 5.4) | 0.7* (0.0 - 6.1) |
Eosinophils (10 3 /ml BAL fluid) | 0.4 (0.0 - 5.1) | 0.3 (0.0 - 4.2) | 0.5 (0.0 - 2.8) | 0.2 (0.0 - 1.2) | 0.1 (0.0 - 3.0) | 0.2 (0.0 - 3.4) |